Has Dwight Im, MD received payments from drug or device companies?

Yes. Drug and device makers reported $93,306 in general payments to Dwight Im, MD across 177 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dwight Im, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dwight Im, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dwight Im, MD

Gynecologic Oncology · Baltimore, MDNPI 1770521130

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Intuitive Surgical at 37.8% of the total. Reporting peaked in 2022 at $28,813 and has fallen 93.4% since, to $1,912 in 2025. Among gynecologic oncology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$93,306in general payments, 2019–2025

Across 177 payments — averaging $527.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$35K
Baxter Healthcare$28K
Momentis Surgical Inc.$10K
Conmed Corporation$10K
Johnson & Johnson$8K
Stryker$499
plus $790 from 17 others

$120,529in research payments, 2019–2025

Across 6 payments — averaging $20,088 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Baxter Healthcare$121K

What the payments were for

Consulting fees$43,93047%
Speaking & faculty fees$29,00031%
Travel & lodging$4,5715%
Food & beverage$14,80516%
Education$1,0001%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	103	$35,250
Baxter Healthcare	24	$28,461
Momentis Surgical Inc.	3	$10,321
Conmed Corporation	3	$10,200
Johnson & Johnson(3 entities)	15	$7,784
Stryker	5	$499
Integra Lifesciences Corporation	2	$239
Caldera Medical, Inc	1	$151
Astellas Pharma US Inc	2	$53
Dysis Medical, Inc.	1	$48
Merck	2	$47
Clovis Oncology, Inc.	3	$36
AbbVie	2	$34
Convatec Inc.	1	$26
Therapeuticsmd, Inc.	2	$25
Seagen Inc.	1	$19
Aesculap, Inc.	1	$19
GSK	1	$18
AstraZeneca	1	$17
Lupin Inc.	1	$16
Coopersurgical, Inc.	1	$15
Millicent US Inc	1	$15
Smith+Nephew	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$93,306 in reported general payments places this provider in the 95th percentile of 35 gynecologic oncology providers in Maryland.

See all gynecologic oncology providers in Maryland →

Medicare billing

Part B allowed, 2024

$794,538

Medicare patients

1,346

Services billed

3,050

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
PremarinEstrogens, Conjugated	19	$9,320
Estradiol	50	$2,751
Clobetasol Propionate	32	$1,417
ValacyclovirValacyclovir Hcl	16	$781
Metronidazole	39	$649
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet	23	$614
Mupirocin	35	$391
Fluconazole	82	$346
Megestrol Acetate	19	$308
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	35	$268
Clindamycin Hcl	17	$178
Nystatin	13	$126
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	12	$49
Ciprofloxacin Hcl	11	$35
Tramadol Hcl	13	$30

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Baltimore

Amanda Nickles-FaderBaltimore$21K
Kara Long RocheBaltimore$5K
Neil RosensheinBaltimore$5K
Sarah LynamBaltimore$3K
Amanda RamosBaltimore$3K
Beman KhulpateeaBaltimore$2K
Dana RoqueBaltimore$2K
Christine O ConnorBaltimore$1K
Hyung RyuBaltimore$973
Teresa Diaz-MontesBaltimore$887

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →